FunPep

Recent Posts

• FunPep is approved the PⅠ/Ⅱa clinical trial plan of FPP003 (antibody-inducing peptide) by HREC in Australia.
• FunPep contracts the joint research agreement with Shionogi for antibody-inducing peptide on pain territory.
• Announcement of fund raising through third-party allotment of new shares
• To develop antibody-inducing peptides for ankylopoietic spondylarthritis, industry-academia collaboration project selected by AMED
• Published the FunPep article on the Nikkei newspapers